Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Aug 27, 2026, 5:43 PM EST
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 11.36 million as of August 28, 2026.
Market Cap
11.36M
Enterprise Value
-844.59K
Revenue
406.44K
Ranking
n/a
PE Ratio
0.76
Stock Price
0.07
ChartMarket Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 11.36M, a decrease of -72.92%. That is a compound annual growth rate of -23.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 11.36M | -22.22% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
| Nov 18, 2021 | 41.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzai Health | 24.06M |
| Rapid Dose Therapeutics | 16.37M |
| Hemostemix | 15.83M |
| PreveCeutical Medical | 15.29M |
| Marvel Biosciences | 9.77M |
| Glow Lifetech | 7.70M |
| Kane Biotech | 6.16M |
| XORTX Therapeutics | 5.54M |